DHX vs MX

DHX exhibits a critically weak deterministic health profile with a Piotroski F-Score of 2/9, signaling significant fundamental deterioration. While the company maintains a strong gross margin (84.66%) and a low debt-to-equity ratio (0.18), it faces severe liquidity constraints evidenced by a current ratio of 0.44. Valuation metrics are attractive with a Price/Sales ratio under 1.0 and a reasonable forward P/E of 13.70, but these are offset by declining year-over-year revenue growth of -10.20%. The stock is a high-risk play where strong earnings beats and analyst optimism clash with deteriorating balance sheet health.

Magnachip (MX) exhibits severe fundamental distress, highlighted by a critical Piotroski F-Score of 0/9, indicating a total lack of improvement in financial health across all measured dimensions. While the company maintains a strong liquidity position with a Current Ratio of 4.07 and low debt (D/E 0.19), these are offset by a collapsing top line, with YoY revenue growth at -20.70% and Q/Q growth at -35.64%. The company is consistently unprofitable with negative operating margins of -30.68%, and the stock is trading at a significant discount to book value (P/B 0.48), suggesting the market is pricing in continued asset impairment or business model failure.